AIC
AXDX

AWM Investment Company’s Accelerate Diagnostics AXDX Stock Holding History

AWM Investment Company’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-40,094
Closed -$281K – 115
2023
Q1 		$281K Sell
40,094
-7,221
-15% -$43.4K 0.04% 112
2022
Q4 		$334K Sell
47,315
-1,795
-4% -$19.6K 0.05% 107
2022
Q3 		$746K Buy
+49,110
New +$813K 0.11% 102

Other funds holding AXDX

GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AWM Investment Company's AXDX Position: Q2 2023 in Review

AWM Investment Company sold out of Accelerate Diagnostics (AXDX) in Q2 2023, closing a stake of 40,094 shares — an estimated $281K sold.

AWM Investment Company first reported a position in AXDX in Q3 2022 and held it in 3 quarters. The position peaked at $746K in Q3 2022. 50 funds tracked by Wall St. Rank hold AXDX as of Q2 2023.

  • AWM Investment Company reported no remaining Accelerate Diagnostics position as of Q2 2023 after selling out during the quarter.
  • AWM Investment Company sold 40,094 Accelerate Diagnostics shares in Q2 2023, an estimated $281K.
  • AWM Investment Company first reported a position in Accelerate Diagnostics in Q3 2022 and held it in 3 quarters.
  • AWM Investment Company's Accelerate Diagnostics position peaked at $746K in Q3 2022.
  • 50 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2023.

Based on AWM Investment Company's 13F filing for Q2 2023, filed 11 Aug 2023.